Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Plasminogen Activator Inhibitor-1 Level in Chronic Serous Chorioretinopathy and Polypoidal Choroidal Vasculopathy

NCT02815176 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02815176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02815176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Plasminogen Activator Inhibitor-1 Level in Chronic Serous Chorioretinopathy and Polypoidal Choroidal Vasculopathy
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2016
Completion date
June 30, 2017
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central serous chorioretinopathy, polypoidal choroidal vasculopathy